These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33008353)

  • 1. The fraction of sensitization among lung transplant recipients in a transplant center in Japan.
    Kumata S; Hirama T; Watanabe Y; Oishi H; Niikawa H; Akiba M; Tikkanen J; Okada Y
    BMC Pulm Med; 2020 Oct; 20(1):256. PubMed ID: 33008353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Single-Center Analysis of How HLA Mismatch and Donor-Specific Antibodies Affect Short-Term Outcome After Lung Transplantation: A Pilot Study Before a Country-Wide Histocompatibility Study in Japan.
    Hirama T; Akiba M; Watanabe T; Watanabe Y; Oishi H; Okada Y
    Transplant Proc; 2024 Mar; 56(2):363-368. PubMed ID: 38320866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch.
    Abdulqawi R; Alawwami M; Aldosari O; Aldosari Z; Alhuqbani M; Saleh RA; Esendagli D; Aldakhil H; De Vol EB; Alkattan K; Marquez KAH; Saleh W; Sandoqa S; Al-Mutairy EA
    Clin Transplant; 2024 Jul; 38(7):e15374. PubMed ID: 38979724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death.
    Zazueta OE; Preston SE; Moniodis A; Fried S; Kim M; Townsend K; Wood I; Boukedes S; Guleria I; Camp P; El-Chemaly S; Rosas IO; Chandraker A; Milford E; Goldberg HJ
    Transplantation; 2017 Sep; 101(9):2207-2212. PubMed ID: 27893614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies.
    Courtwright AM; Cao S; Wood I; Mallidi HR; Kawasawa J; Moniodis A; Ng J; El-Chemaly S; Goldberg HJ
    Ann Am Thorac Soc; 2019 Sep; 16(9):1131-1137. PubMed ID: 31026404
    [No Abstract]   [Full Text] [Related]  

  • 10. Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay.
    Brugière O; Suberbielle C; Thabut G; Lhuillier E; Dauriat G; Metivier AC; Gautreau C; Charron D; Mal H; Parquin F; Stern M
    Transplantation; 2013 Mar; 95(5):761-5. PubMed ID: 23296148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients.
    Park JE; Kim CY; Park MS; Song JH; Kim YS; Lee JG; Paik HC; Kim SY
    BMC Pulm Med; 2018 Mar; 18(1):45. PubMed ID: 29529999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of how immune sensitization is defined prior to lung transplantation.
    Chin N; Paraskeva M; Paul E; Cantwell L; Levvey B; Williams T; Snell G; Westall G
    Hum Immunol; 2015 Oct; 76(10):711-6. PubMed ID: 26429328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human leukocyte antigen immunologic risk stratification methods in lung transplantation.
    Hiho SJ; Levvey BJ; Diviney MB; Snell GI; Sullivan LC; Westall GP
    Am J Transplant; 2024 May; 24(5):827-838. PubMed ID: 37981213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the current post-transplantation Human Leukocyte Antigen antibody screening in pediatric renal transplant recipients.
    Demirok A; Ranzijn C; Lardy J; Florquin S; Bouts A
    Pediatr Transplant; 2019 Mar; 23(2):e13338. PubMed ID: 30635959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Transplantation and the Era of the Sensitized Patient.
    Young KA; Ali HA; Beermann KJ; Reynolds JM; Snyder LD
    Front Immunol; 2021; 12():689420. PubMed ID: 34122454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated human leukocyte antigen mismatches in lung re-transplantation.
    Sommer W; Hallensleben M; Ius F; Kühn C; Tudorache I; Avsar M; Salman J; Siemeni T; Greer M; Gottlieb J; Boethig D; Blasczyk R; Haverich A; Warnecke G
    Transpl Immunol; 2017 Feb; 40():1-7. PubMed ID: 27923603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited impact of pre-existing donor specific HLA-antibodies (DSA) on long term allograft survival after first adult liver transplantation.
    Koch M; Marget M; Sterneck M; Fischer L; Thude H; Nashan B
    Hum Immunol; 2018 Jul; 79(7):545-549. PubMed ID: 29669260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.